Implementing Vitamin D guidance: draft guideline consultation
NICE is developing a public health guideline on Vitamin D: implementation of existing guidance to prevent deficiency
All registered stakeholders for the above public health guideline are invited to comment on the provisional recommendations via this website during a 6 week consultation with stakeholders.
Organisations not registered as stakeholders are not able to comment.
Please note - the provisional recommendations presented here do not constitute NICE’s formal guideline on this topic. The recommendations are provisional and may change after consultation.
This consultation will take place between 13 May - 24 June 2014
The draft guideline sets out the provisional recommendations that have been developed.
This guideline aims to improve the implementation of existing recommendations on vitamin D to prevent deficiency. It focuses, in particular, on advice for at-risk groups to take a vitamin D supplement.
The benefits and risks of safe sunlight exposure is being covered in a separate guideline (more information here).
SACN is currently reviewing the dietary reference values for vitamin D intake in the UK population. The recommendations here should be read in conjunction with any advice published by SACN.
NICE is issuing a second call for evidence to support the development of public health guideline on ‘Vitamin D: implementation of existing guidance to prevent deficiency’. Further information can be found here.
Please note - Comments forms with attachments such as research articles, letters or leaflets will not be accepted. If comments forms do have attachments they will be returned without being read. If the stakeholder resubmits the form without attachments, it must be by the consultation deadline.
Implementing Vitamin D guidance: Draft Guideline
Implementing Vitamin D guidance: Draft Guideline Stakeholder Comments Form
Points to consider in the consultation:
- Points or areas that are not covered, but which appear to fall within the scope of the guideline.
- Potential inconsistencies or any disagreement with the Public Health Advisory Committee’s interpretation of the evidence and its applicability.
- The practical value of the provisional recommendations.
- Issues of presentation and style, including how the provisional recommendations have been grouped and ordered.
- Whether the right organisations and individuals have been identified under ‘Who should take action’ for each recommendation.
Do you think this guideline could be improved to better promote equality of opportunity relating to age, disability, gender, gender identity, ethnicity, religion and belief, sexual orientation or socio-economic status? If so, please include details of:
- Which particular parts of the guideline you think affect equality of opportunity.
- Why and how you think equality of opportunity is affected.
- In addition are there any reasons why any of the recommendations in the guideline may result in an increase in inequality of opportunity relating to age, disability, gender, gender identity, ethnicity, religion and belief, sexual orientation or socio-economic status?
How to submit your comments
Please provide all responses to the draft guideline using the Stakeholder Comments Form (ensuring all relevant fields are completed, including your organisation's name). Please forward the form by 24 June 2014 at the very latest to VitaminDdeficiency@nice.nhs.uk
The Institute is unable to accept:
- More than one response per stakeholder organisation
- Comments received after the consultation deadline
- Comments that are not complete on a stakeholder comments form
- Confidential information or other material that you would not wish to be made public
Comments forms with attachments such as research articles, letters or leaflets. If comments forms do have attachments they will be returned without being read. If the stakeholder resubmits the form without attachments, it must be by the consultation deadline.
What will happen to your comments?
- All comments (with the exception of personal, individual comments and late comments) will be sent to the project team at the end of the consultation
- Comments from registered stakeholders will be formally responded to by the project team and posted on the NICE website after the final guideline is published.
- No action will be taken upon receipt of personal, individual comments and late comments.
PLEASE NOTE: The Institute reserves the right to summarise and edit comments received during consultations, or not to publish them at all, where in the reasonable opinion of the Institute, the comments are voluminous, publication would be unlawful or publication would be otherwise inappropriate.
The following evidence was used by the Public Health Advisory Committee in developing the provisional recommendations.
This page was last updated: 13 June 2014